Insulet (PODD) Misses Q4 EPS by 22c, Guidance Comes in Light
Tweet
Share
E-mailGet Alerts PODD Hot Sheet
Price: $144.48 +3.96%
EPS Growth %: +24.8%
Financial Fact:
Research and development: 13.73M
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: +24.8%
Financial Fact:
Research and development: 13.73M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Insulet (NASDAQ: PODD) reported Q4 EPS of ($0.48), $0.22 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $100.1 million versus the consensus estimate of $91.89 million.
GUIDANCE:
Insulet sees Q1 2016 revenue of $77-80 million, versus the consensus of $83.19 million.
Insulet sees FY2016 revenue of $330-350 million, versus the consensus of $360.08 million.
For earnings history and earnings-related data on Insulet (PODD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank Starts Insulet Corporation (PODD) at Buy
- Goldman "broadly" raises estimates for LTL and truckload stocks
- Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
